Shabeeb, Z. A., Y. F. Faraj, B. A. Mtashar, M. S. Hussein, and A. F. Hasan. “Immune-Biomarker Signature Predicts Early Molecular Response in Iraqi Chronic Myeloid Leukemia Patients Receiving Front-Line Tyrosine-Kinase Inhibitors”. Regulatory Mechanisms in Biosystems, Vol. 16, no. 4, Dec. 2025, p. e25197, doi:10.15421/0225197.